Invention:
This invention is an antimicrobial compound made of nucleic acid that can treat diseases caused by the pathogens Neisseria Gonorrhoeae (Ngo) and Neisseria Meningitidis (Nme).
Background:
Ngo is a common cause of infection globally, and when left untreated, it can cause pelvic inflammatory disease, infertility issues and increased susceptibility to HIV. Many Neisseria strains are antibiotic resistant and are very hard to clear from the system. Current standards require dual therapy in order to try to combat the infection and reduce further development of antibiotic resistance. There is a large need for new therapeutic options to fight Neisseria infections.
Applications:
- Therapeutic option for treating bacterial disease
- Treatment against Nme and Ngo pathogens
Advantages:
- Provides several potential models of delivery
- Ease of delivery
- Dual functionality
- Highly effective
Status: issued U.S. Patent #10,900,043
